Personalized dose selection in radiation therapy using statistical models for toxicity and efficacy with dose and biomarkers as covariates.

Abstract:

:Selection of dose for cancer patients treated with radiation therapy (RT) must balance the increased efficacy with the increased toxicity associated with higher dose. Historically, a single dose has been selected for a population of patients (e.g., all stage III non-small cell lung cancer). However, the availability of new biologic markers for toxicity and efficacy allows the possibility of selecting a more personalized dose. We consider the use of statistical models for toxicity and efficacy as a function of RT dose and biomarkers to select an optimal dose for an individual patient, defined as the dose that maximizes the probability of efficacy minus the sum of weighted toxicity probabilities. This function can be shown to be equal to the expected value of the utility derived from a particular family of bivariate outcome utility matrices. We show that if dose is linearly related to the probability of toxicity and efficacy, then any marker that only acts additively with dose cannot improve efficacy, without also increasing toxicity. Using a dataset of lung cancer patients treated with RT, we illustrate this approach and compare it to non-marker-based dose selection. Because typical metrics used in evaluating new markers (e.g., area under the ROC curve) do not directly address the ability of a marker to improve efficacy at a fixed probability of toxicity, we utilize a simulation study to assess the effects of marker-based dose selection on toxicity and efficacy outcomes.

journal_name

Stat Med

journal_title

Statistics in medicine

authors

Schipper MJ,Taylor JM,TenHaken R,Matuzak MM,Kong FM,Lawrence TS

doi

10.1002/sim.6285

subject

Has Abstract

pub_date

2014-12-30 00:00:00

pages

5330-9

issue

30

eissn

0277-6715

issn

1097-0258

journal_volume

33

pub_type

杂志文章
  • What do we mean by validating a prognostic model?

    abstract::Prognostic models are used in medicine for investigating patient outcome in relation to patient and disease characteristics. Such models do not always work well in practice, so it is widely recommended that they need to be validated. The idea of validating a prognostic model is generally taken to mean establishing tha...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(20000229)19:4<453::aid-sim

    authors: Altman DG,Royston P

    更新日期:2000-02-29 00:00:00

  • Current development in clinical trials: issues old and new.

    abstract::Clinical trials, especially the randomized clinical trial, have been and will remain the gold standard for the evaluation of new interventions, including pharmaceuticals, biologics, medical devices, procedures, or behavioral modifications. Despite more than five decades of experience, there are still challenges in the...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5405

    authors: DeMets DL

    更新日期:2012-11-10 00:00:00

  • Precision of incidence predictions based on Poisson distributed observations.

    abstract::Disease incidence predictions are useful for a number of administrative and scientific purposes. The simplest ones are made using trend extrapolation, on either an arithmetic or a logarithmic scale. This paper shows how approximate confidence prediction intervals can be calculated for such predictions, both for the to...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780131503

    authors: Hakulinen T,Dyba T

    更新日期:1994-08-15 00:00:00

  • Two-stage sampling in pharmaceutical applications.

    abstract::In the pharmaceutical industry, some tests for quality assurance before, during and after the manufacture of a drug product involve a two-stage sampling technique. We propose statistical testing procedures in a two-stage sampling problem with large within-class sample sizes. We also derive a two-stage sampling plan by...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780122104

    authors: Shao J,Chow SC

    更新日期:1993-11-15 00:00:00

  • The power prior: theory and applications.

    abstract::The power prior has been widely used in many applications covering a large number of disciplines. The power prior is intended to be an informative prior constructed from historical data. It has been used in clinical trials, genetics, health care, psychology, environmental health, engineering, economics, and business. ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6728

    authors: Ibrahim JG,Chen MH,Gwon Y,Chen F

    更新日期:2015-12-10 00:00:00

  • Determining the size of a cross-sectional sample to estimate the age-specific incidence of an irreversible disease.

    abstract::The design of a cross-sectional survey to estimate the age-specific incidence of an irreversible disease is considered, where the incidence rate is not changing over time and the risk of mortality is not affected by the onset of disease. The sample is assumed to give information on the current age and disease status o...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780132208

    authors: Marschner IC

    更新日期:1994-11-30 00:00:00

  • Robust estimation for linear panel data models.

    abstract::In different fields of applications including, but not limited to, behavioral, environmental, medical sciences, and econometrics, the use of panel data regression models has become increasingly popular as a general framework for making meaningful statistical inferences. However, when the ordinary least squares (OLS) m...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8732

    authors: Hamiye Beyaztas B,Bandyopadhyay S

    更新日期:2020-12-20 00:00:00

  • Group sequential testing of the predictive accuracy of a continuous biomarker with unknown prevalence.

    abstract::Group sequential testing procedures have been proposed as an approach to conserving resources in biomarker validation studies. Previously, we derived the asymptotic properties of the sequential empirical positive predictive value (PPV) and negative predictive value (NPV) curves, which summarize the predictive accuracy...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6790

    authors: Koopmeiners JS,Feng Z

    更新日期:2016-04-15 00:00:00

  • Predictive accuracy of risk factors and markers: a simulation study of the effect of novel markers on different performance measures for logistic regression models.

    abstract::The change in c-statistic is frequently used to summarize the change in predictive accuracy when a novel risk factor is added to an existing logistic regression model. We explored the relationship between the absolute change in the c-statistic, Brier score, generalized R(2) , and the discrimination slope when a risk f...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5598

    authors: Austin PC,Steyerberg EW

    更新日期:2013-02-20 00:00:00

  • Biomarker discovery using targeted maximum-likelihood estimation: application to the treatment of antiretroviral-resistant HIV infection.

    abstract::Researchers in clinical science and bioinformatics frequently aim to learn which of a set of candidate biomarkers is important in determining a given outcome, and to rank the contributions of the candidates accordingly. This article introduces a new approach to research questions of this type, based on targeted maximu...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3414

    authors: Bembom O,Petersen ML,Rhee SY,Fessel WJ,Sinisi SE,Shafer RW,van der Laan MJ

    更新日期:2009-01-15 00:00:00

  • Drug treatment of mild hypertension to reduce the risk of CHD: is it worth-while?

    abstract::Although hypertension is regarded as a causal factor for coronary heart disease (CHD) a reduction in the risk of CHD as a result of lowering blood pressure in mild hypertension could not be demonstrated. This conclusion is based on an overview analysis of all published randomized trials in mild hypertension, including...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780071104

    authors: Holme I

    更新日期:1988-11-01 00:00:00

  • The CUSCORE test and the q-interval in cluster analyses of colon cancer and of lymphoma among asbestos workers.

    abstract::Exposure to a carcinogen is likely to be reflected by temporal clustering of cancer cases among the community members. Detection of such clustering is a complicated task in general and more so in a small workplace community with low turnover rate. In this study we applied the CUSCORE test and the q-interval statistic ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1534

    authors: Chen R,Froom P

    更新日期:2003-10-15 00:00:00

  • Modelling the association between patient characteristics and the change over time in a disease measure using observational cohort data.

    abstract::In observational cohort studies we may wish to examine the associations between fixed patient characteristics and the longitudinal changes from baseline in a repeated outcome measure. Many biological and other outcome measures are known to be subject to measurement error and biological variation. In an initial analysi...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3725

    authors: Harrison L,Dunn DT,Green H,Copas AJ

    更新日期:2009-11-20 00:00:00

  • A random effects model for ordinal responses from a crossover trial.

    abstract::Crossover studies have been successfully conducted in the case of continuous responses. Existing procedures of analysis for ordinal responses, on the other hand, are rarely satisfactory unless strict, usually unrealistic, assumptions are made. In this paper we investigate a random effects model and show that the model...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780100611

    authors: Ezzet F,Whitehead J

    更新日期:1991-06-01 00:00:00

  • Mixture distributions in multi-state modelling: some considerations in a study of psoriatic arthritis.

    abstract::In many studies, interest lies in determining whether members of the study population will undergo a particular event of interest. Such scenarios are often termed 'mover-stayer' scenarios, and interest lies in modelling two sub-populations of 'movers' (those who have a propensity to undergo the event of interest) and ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5529

    authors: O'Keeffe AG,Tom BD,Farewell VT

    更新日期:2013-02-20 00:00:00

  • Testing departure from additivity in Tukey's model using shrinkage: application to a longitudinal setting.

    abstract::While there has been extensive research developing gene-environment interaction (GEI) methods in case-control studies, little attention has been given to sparse and efficient modeling of GEI in longitudinal studies. In a two-way table for GEI with rows and columns as categorical variables, a conventional saturated int...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6281

    authors: Ko YA,Mukherjee B,Smith JA,Park SK,Kardia SL,Allison MA,Vokonas PS,Chen J,Diez-Roux AV

    更新日期:2014-12-20 00:00:00

  • Smoothing across time in repeated cross-sectional data.

    abstract::Repeated cross-sectional samples are common in national surveys of health like the National Health Interview Survey (NHIS). Because population health outcomes generally evolve slowly, pooling data across years can improve the precision of current-year annual estimates of disease prevalence and other health outcomes. P...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3897

    authors: Lockwood JR,McCaffrey DF,Setodji CM,Elliott MN

    更新日期:2011-02-28 00:00:00

  • Sequential designs for phase III clinical trials incorporating treatment selection.

    abstract::Most statistical methodology for phase III clinical trials focuses on the comparison of a single experimental treatment with a control. An increasing desire to reduce the time before regulatory approval of a new drug is sought has led to development of two-stage or sequential designs for trials that combine the defini...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1362

    authors: Stallard N,Todd S

    更新日期:2003-03-15 00:00:00

  • Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry.

    abstract::In the analysis of survival data, there are often competing events that preclude an event of interest from occurring. Regression analysis with competing risks is typically undertaken using a cause-specific proportional hazards model. However, modern alternative methods exist for the analysis of the subdistribution haz...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4123

    authors: Lau B,Cole SR,Gange SJ

    更新日期:2011-03-15 00:00:00

  • Estimating inverse probability weights using super learner when weight-model specification is unknown in a marginal structural Cox model context.

    abstract::Correct specification of the inverse probability weighting (IPW) model is necessary for consistent inference from a marginal structural Cox model (MSCM). In practical applications, researchers are typically unaware of the true specification of the weight model. Nonetheless, IPWs are commonly estimated using parametric...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7266

    authors: Karim ME,Platt RW,BeAMS study group.

    更新日期:2017-06-15 00:00:00

  • Local influence measure of zero-inflated generalized Poisson mixture regression models.

    abstract::In many practical applications, count data often exhibit greater or less variability than allowed by the equality of mean and variance, referred to as overdispersion/underdispersion, and there are several reasons that may lead to the overdispersion/underdispersion such as zero inflation and mixture. Moreover, if the c...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5560

    authors: Chen XD,Fu YZ,Wang XR

    更新日期:2013-04-15 00:00:00

  • Four-fold table cell frequencies imputation in meta analysis.

    abstract::Meta analysis is a collection of quantitative methods devoted to combine summary information from related but independent studies. Because research reports usually present only data reductions and summary statistics rather than detailed data, the reviewer must often resort to rather crude methods for constructing summ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2287

    authors: Di Pietrantonj C

    更新日期:2006-07-15 00:00:00

  • Covariate adjusted mixture models and disease mapping with the program DismapWin.

    abstract::The analysis and recognition of disease clustering in space and its representation on a map is an important problem in epidemiology. An approach using mixture models to identify spatial heterogeneity in disease risk and map construction within an empirical Bayes framework is described. Once heterogeneity is detected, ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(19960415)15:7/9<919::aid-s

    authors: Schlattmann P,Dietz E,Böhning D

    更新日期:1996-04-15 00:00:00

  • The Peto odds ratio viewed as a new effect measure.

    abstract::Meta-analysis has generally been accepted as a fundamental tool for combining effect estimates from several studies. For binary studies with rare events, the Peto odds ratio (POR) method has become the relative effect estimator of choice. However, the POR leads to biased estimates for the OR when treatment effects are...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6301

    authors: Brockhaus AC,Bender R,Skipka G

    更新日期:2014-12-10 00:00:00

  • Quantifying the bias due to observed individual confounders in causal treatment effect estimates.

    abstract::It is often of interest to use observational data to estimate the causal effect of a target exposure or treatment on an outcome. When estimating the treatment effect, it is essential to appropriately adjust for selection bias due to observed confounders using, for example, propensity score weighting. Selection bias du...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8549

    authors: Parast L,Griffin BA

    更新日期:2020-08-15 00:00:00

  • A discussion on the conventional estimator of sensitivity and specificity in multiple tests.

    abstract::Both the variation of positive responses (negative responses) among individuals and the internal correlation among responses for the same individual affect the precision of the estimate of sensitivity (specificity). To estimate the sensitivity (specificity) of a medical diagnostic test, this paper proposes a Bayesian ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780081007

    authors: Lui KJ

    更新日期:1989-10-01 00:00:00

  • On the three-arm non-inferiority trial including a placebo with a prespecified margin.

    abstract::Three-arm trials including the experimental treatment, an active reference treatment and a placebo are recommended in the guidelines of the ICH and EMEA/CPMP as a useful approach to the assessment of assay sensitivity. Generally, the acceptable non-inferiority margin Δ has been defined as the maximum clinically irrele...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4099

    authors: Hida E,Tango T

    更新日期:2011-02-10 00:00:00

  • Sample size planning for survival prediction with focus on high-dimensional data.

    abstract::Sample size planning should reflect the primary objective of a trial. If the primary objective is prediction, the sample size determination should focus on prediction accuracy instead of power. We present formulas for the determination of training set sample size for survival prediction. Sample size is chosen to contr...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5550

    authors: Götte H,Zwiener I

    更新日期:2013-02-28 00:00:00

  • Robust Bayesian sample size determination in clinical trials.

    abstract::This article deals with determination of a sample size that guarantees the success of a trial. We follow a Bayesian approach and we say an experiment is successful if it yields a large posterior probability that an unknown parameter of interest (an unknown treatment effect or an effects-difference) is greater than a c...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3175

    authors: Brutti P,De Santis F,Gubbiotti S

    更新日期:2008-06-15 00:00:00

  • Multiple outputation for the analysis of longitudinal data subject to irregular observation.

    abstract::Observational cohort studies often feature longitudinal data subject to irregular observation. Moreover, the timings of observations may be associated with the underlying disease process and must thus be accounted for when analysing the data. This paper suggests that multiple outputation, which consists of repeatedly ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6829

    authors: Pullenayegum EM

    更新日期:2016-05-20 00:00:00